Research discovers fibronectin’s role in BRAF-mutant thyroid cancer resistance

New research overseen by University of Colorado Cancer Center member Rebecca Schweppe, PhD, could lead to improved treatment for people with thyroid cancer characterized by a mutation in the BRAF gene -; a mutation also responsible for some types of melanoma, colorectal cancer, leukemia, lymphoma, and ovarian cancer.

M&A activity in the pharmaceutical industry in Sweden increased in 2024

In value terms, M&A activity in Sweden remained flat in Q1 2024 compared with the previous quarter and as compared to Q1 2023. Related deal

May 22, 2024

Philips stops selling sleep, respiratory devices in US due to FDA consent decree

Listen to the article 4 min This audio is auto-generated. Please let us know if you have feedback. By the numbers Q4 sales: 5.06 billion

January 29, 2024

Understanding how aging impacts memory and learning

Our brains change as we age, and connections between the different parts of the brain become less efficient.

October 15, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.